Pfizer Ngenla 60 mg Prefilled Pen is a long-acting growth hormone medicine used in the treatment of growth hormone deficiency (GHD), mainly in children and adolescents. It is designed to replace the growth hormone that the body does not produce in sufficient amounts.
The pen is intended for subcutaneous use and is designed for simple self-administration or caregiver administration. Each prefilled pen delivers precise doses as prescribed by a healthcare professional and is used once weekly.
How It Works?
Pfizer Ngenla 60mg pen works by acting like the natural growth hormone produced by the pituitary gland. After injection, the medicine is gradually released into the bloodstream over a full week. It helps:
- Stimulate bone and tissue growth
- Increase muscle development
- Support protein synthesis
- Regulate fat and carbohydrate metabolism
The long-acting formulation ensures stable hormone levels with fewer injections.
Dosage :
Administered once weekly via subcutaneous injection using the prefilled pen. The dose is determined by the patient’s body weight and clinical condition. Injection sites (abdomen, thigh, or upper arm) should be rotated.
The prefilled pen is designed to deliver the exact prescribed dose. Use only as directed by a healthcare provider. Do not alter the dose or frequency.
Benefits :
- Prefilled pen ensures easy and accurate dosing
- Once-weekly injection reduces treatment burden
- Helps promote normal growth and development
- Improves treatment adherence
- Suitable for home use with proper training
Side Effects :
Common side effects may include:
- Injection site reactions (pain, redness, swelling)
- Headache
- Fatigue
- Muscle or joint pain
Conclusion :
Pfizer Ngenla 60mg Prefilled Pen offers an effective and user-friendly solution for managing growth hormone deficiency. Its long-acting formulation and easy-to-use pen design reduce injection frequency while ensuring accurate dosing. When used under medical supervision, Ngenla supports healthy growth, development, and overall well-being.







Reviews
There are no reviews yet.